Safety Study of WIN378 for Moderate-Severe COPD
Part of Lungs & breathing clinical trials.
This study tests a new drug called WIN378 in people with moderate-to-severe COPD (chronic lung disease). It will check if the drug is safe and how the body processes it, which may help improve breathing and reduce flare-ups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 40 and 80 years old
- Have moderate-to-severe COPD confirmed by breathing tests (FEV1 between 30–80% of predicted normal)
- Be on stable triple inhaled therapy (three COPD inhalers) for at least 3 months with no recent changes
- Have smoked at least 10 pack-years in the past but quit at least 6 months ago
- Have higher-than-normal eosinophil counts (a type of white blood cell)
- Have a stable weight and BMI in an acceptable range
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental medicine called R-3750 to see if it is safe and helpful for people with mild to moderate COPD. It is an early-phase trial, so the main goal is safety, but they will also look at how your breathing responds.
This study tests an experimental drug called JKN2403 for people with moderate to severe COPD. It aims to see if the drug can reduce flare-ups and improve breathing compared to a placebo (a dummy pill).
This study tests an experimental drug for people with moderate to severe COPD, especially those with chronic bronchitis. It aims to see how the drug affects certain markers in your body and whether it helps with your COPD symptoms.
This study tests a new medication (GSK5784283) for people with moderate to severe COPD who have a certain type of inflammation (eosinophilic). Participants must be on standard inhaler therapy and have a history of smoking. The trial will compare the new drug to a placebo.
This trial tests a new medicine called PF-07275315 for people with moderate to severe COPD. It aims to see if it can help reduce flare-ups (sudden worsening of symptoms) when added to your usual treatment.
This study tests an experimental medication for chronic obstructive pulmonary disease (COPD) in two parts: first in healthy volunteers, then in people with COPD. It aims to see if the drug is safe and how well it works.
Hear when a new COPD (Chronic Obstructive Pulmonary Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.